| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.64 | 4e-05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.59 | 5e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.61 | 9e-05 |